Submissions
Online Submissions
Already have a Username/Password for Consortium PSYCHIATRICUM?
Go to Login
Need a Username/Password?
Go to Registration
Registration and login are required for submitting items online, and for checking the status of current submissions.
Author Guidelines
WHY PUBLISH IN CONSORTIUM PSYCHIATRICUM
Publishing in Consortium PSYCHIATRICUM is a direct path to presenting your research to the international scientific community.
SCOPE
- High Ranking: The journal is ranked #1 among Russian publications and is positioned in Q3 in three SCImago Journal Rank (SJR) categories: Psychiatry and Mental Health; Public Health, Environmental and Occupational Health; and Clinical Psychology.
- Citation Growth:The journal demonstrates stable growth in citations, with a current Scopus CiteScore Tracker of 2.8 (February 2026). Its two-year RSCI Impact Factor is 1.634 (2024). Notably, 70% of the journal's citations come from international and Russian journals indexed in Web of Science (WoS) and Scopus.
- Active Readership: Articles published in the journal have garnered over 1.5 million views and downloads. More than 1,700 subscribers follow new publications across Russian and international social media channels.
- Media Coverage: Research published in the journal is regularly featured in leading media outlets, accumulating over 150 media mentions in 2024–2025.
- International Collaboration: The journal's Editorial Board comprises 29 leading experts from 12 countries. Authors from 35 countries have published in the journal, accounting for approximately 30% of all publications.
- Indexation: Scopus, PubMed, WPA recommended reading list.
COMPREHENSIVE AUTHOR SUPPORT
- Editorial Platform: A streamlined online system for manuscript submission and tracking.
- Multi-Level Quality Assessment: Manuscripts undergo rigorous peer review, scientific editing, and copyediting to ensure high scientific quality and value.
- Methodological Guidance: Detailed author guidelines assist in preparing manuscripts and accurately describing research findings.
- Professional Translation: Accepted manuscripts are translated into either Russian or English with scientific precision. This makes research by Russian authors accessible to a global audience and work by international colleagues available to Russian-speaking readers.
- Proofreading.
- Illustration Design: We create and refine graphs, charts, and diagrams to ensure clear and compelling data visualization.
- Open Access: All articles are published open access under a Creative Commons license, ensuring free and unrestricted dissemination.
- Promotion & Visibility: We write and distribute press releases, produce video abstracts, podcasts, and expert interviews with authors, and actively promote articles on social media.
- Real-Time Metrics: Authors receive real-time statistics on article views, downloads, and citations.
- PubMed Central (PMC): All published scientific articles are deposited in PubMed Central (PMC), the premier electronic archive for biomedical literature, significantly increasing their global visibility and citation potential.
TRANSPARENT EDITORIAL PROCESS
- Stringent Scientific Selection: The editorial board accepts only 19% of submitted manuscripts, ensuring the publication of only the most significant research.
- Transparent Process:The entire editorial workflow — from submission to publication — is managed online. All participants (authors, reviewers, editors) can track the manuscript's status and their tasks in real time. The editorial office maintains constant communication and keeps authors informed. Each manuscript typically undergoes no more than 3 rounds of review by the scientific editor and reviewers. Watch our video about the editorial process.
- Fast Publication Timelines:
- A decision on initial suitability is made within an average of 5 days of submission.
- Following final acceptance, articles are published Online First within 21 days.
- Online First Publication: Accepted articles are published on the journal's website in the "Accepted Articles" section with a DOI assigned immediately. From the day of Online First publication, the article is fully accessible and citable.
ARTICLE PREPARATION
Eligibility criteria
Before submitting your manuscript to Consortium PSYCHIATRICUM, please ensure it meets the following requirements (you may also verify your manuscript using our pre-submission checklist):Journal's scope: psychiatry, clinical psychology, psychotherapy, public health and healthcare organization, epidemiology of mental disorders, fundamental research in neuropsychology and psychiatry, and related interdisciplinary studies.
Article type: Original research, review, clinical case, study protocol, opinion, etc. (see specific requirements for each article type).
- Structure: according to the subsequent Equator Network publication guideline.
Language: Is written in English.
Scientific novelty and relevance, with conclusions that are meaningful to mental health professionals.
Clear, scientific language that is accessible to specialists in adjacent fields.
Is original: Is not under consideration by any other publication and has not been published previously.
- When preparing a manuscript for submission, authors should adhere to guidelines based on the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations), developed by the International Committee of Medical Journal Editors.
Article types
The Consortium PSYCHIATRICUM journal considers manuscripts of various types. Please ensure you are familiar with the basic formatting requirements for your chosen publication format.
Manuscript Type | Examples / EQUATOR Network Reporting Guideline* | General Formatting Requirements |
RESEARCH | 1. Diagnostic Study / STARD. | • Title: Must indicate the study design. |
REVIEW | 1. Systematic Review / PRISMA (example). | • Title: Must specify the review type. |
CLINICAL CASE | • Title: Must include "case report." | |
PROTOCOL | • Title: Must include "Study Protocol." |
Note: *The list of guidelines above is not exhaustive. If none of the listed guidelines fit your study, please use the EQUATOR Network library search (available by study type, clinical area, manuscript section, or keywords) to select an appropriate one independently.
The editorial board also considers other manuscript types beyond those listed above. For these materials, abstract and main text structure may be flexible. These manuscripts undergo peer review only:
- Special Article — A concise review summarizing accumulated experience and providing an overview of outpatient psychiatric care in different countries (see structure and example).
- Historical Perspective — An article on the evolution of treatment approaches for mental disorders and the organization of psychiatric care (example).
- Information — A brief summary reporting on healthcare organization updates, significant events, and dates (example).
- Short Communication — A concise report on psychiatric research findings (example).
- Discussion — An author's analysis of existing research and new perspectives on known problems (example).
- Editorial — Materials serving as a platform for discussions on the future of psychiatry, highlighting important topics requiring the attention of the scientific community (example).
- Commentary — A brief expert evaluation of a current scientific issue, a published article, or a significant event in the field (example).
- Opinion — A personal, well-argued perspective on a controversial or current issue in science or clinical practice (example).
- Policy Statement — A formal presentation of the agreed position of a professional community, scientific organization, or panel of leading experts on a key issue in psychiatry and mental healthcare (example).
Determine research type
Accurately defining your study design is the essential first step toward successful publication. It ensures you select the appropriate reporting guideline (e.g., CONSORT, STROBE, PRISMA) and structure your manuscript to meet the journal's standards.
Consortium PSYCHIATRICUM publishes original research characterized by scientific novelty, clinical relevance, and robust methodology. We also welcome submissions reporting null or negative results, provided the research question is significant and the study design is sound. To determine your study type, you can also refer to the algorithm provided in the article.
Types of studies considered by the editorial board:
1. PRIMARY STUDIES (REPORTING NEW DATA)
Interventional Studies
- Randomized Controlled Trial (RCT): Participants are randomly allocated to groups to compare the effects of different interventions (e.g., a new therapy vs. standard care). This design provides the highest level of evidence for establishing causality (reporting guideline: CONSORT).
Observational Studies (reporting guideline: STROBE)
- Cohort Study: A group (cohort) with a common characteristic or exposure is followed forward in time to observe outcomes. Can be prospective (preferred) or retrospective.
- Case-Control Study: Groups are selected based on the presence ('cases') or absence ('controls') of an outcome, and past exposures are compared retrospectively.
- Cross-Sectional Study: Data on exposures and outcomes are collected at a single point in time, assessing prevalence. It cannot establish temporal sequence.
Diagnostic Studies
- Diagnostic Accuracy Study: Evaluates the performance of a new diagnostic or prognostic tool against a reference standard (reporting guideline: STARD).
2. SECONDARY STUDIES (SYNTHESIS OF EXISTING EVIDENCE)
- Systematic Review & Meta-Analysis: A comprehensive, reproducible search and critical synthesis of all relevant studies on a focused question (reporting guideline: PRISMA or PRISMA-ScR).
- Clinical Guideline or Consensus Statement: Practice recommendations derived from systematic reviews of the evidence. International, multidisciplinary efforts are prioritized.
- Narrative Review: A scholarly analysis of the current state of science on a topic, offering novel interpretation or conceptual models (reporting guideline: Narrative Review Checklist).
3. METHODOLOGICAL AND FOUNDATIONAL RESEARCH
- Study Protocol: A detailed plan for a future or ongoing major study (e.g., RCT, systematic review), published to enhance transparency (reporting guideline: SPIRIT ).
- Psychometric Study: Validation or cultural adaptation of diagnostic scales, questionnaires, or assessment tools (reporting guideline: TARES).
- Big Data & Modeling Studies: Application of machine learning, analysis of electronic health records, or genomic data to address psychiatric questions (reporting guideline: TRIPOD-AI).
Guidelines for the Use of Artificial Intelligence
- Author Responsibility and Oversight
AI must serve strictly as an auxiliary tool in manuscript preparation, not as a substitute for substantive intellectual contribution. Authors bear full and final responsibility for the accuracy, integrity, and validity of all manuscript content. This includes verifying every claim, citation, reference, and analytical procedure. All conclusions and core arguments must originate from the authors' own critical thinking and expert judgment. Any content created or significantly refined with AI assistance must undergo meticulous review and validation by the authors prior to submission. The final manuscript must unequivocally reflect the authors' unique scholarly contribution, adhere to their stylistic voice, and comply with the journal's ethical and editorial standards.
- Disclosure of AI Use
Authors are required to declare any use of AI tools during manuscript preparation in a transparent and structured manner.
- AI in the Research Process: If AI was used directly in the research methodology (e.g., for data processing, literature synthesis, code generation, image analysis), this must be described in detail within the Methods section. The description should enable independent reproducibility and include:
- Name of the AI tool/software/platform.
- Version number and developer/provider.
- Access point (URL, if applicable).
- A clear description of the application workflow.
- Identification of the researcher(s) who operated the tool.
- The specific prompts/queries used (sequence and details).
- Dates of use (where relevant).
- A statement on how the authors verified the accuracy and reliability of the AI-generated outputs.
Examples:
| "An initial screening of over 500 article abstracts was performed using GPT-4 (accessed January 2025) to categorize them according to the pre-defined criteria. All AI-assisted categorizations were subsequently verified and validated by the authors, who made the final inclusion/exclusion decisions." |
| "Regression analysis scripts were initially generated using Claude 3.5 Sonnet (accessed August 2025). All AI-generated code was reviewed, tested, and refined by the authors, who confirm the accuracy and reproducibility of the final analytical outputs." |
| "Thematic analysis of qualitative interview data was assisted by LLAMA 3 (accessed May 2025). All AI-suggested themes were reviewed and validated by the authors to ensure interpretive accuracy. Prompts and model parameters are provided in Appendix S2. All data were anonymized prior to AI-assisted analysis in compliance with institutional confidentiality protocols." |
- AI in Figure/Illustration Creation: Disclosure is mandatory if AI tools were used to create or substantively edit any visual material (graphs, diagrams, schematics, or data-derived artwork) included in the manuscript. The figure caption must specify:
- Name and version of the AI tool.
- Year of use.
- The specific role of the AI (e.g., "for initial concept generation," "for layout assembly").
- The author's role in guiding the process and validating/editing the final output.
Important Restrictions: The use of AI to create, modify, or enhance factual, evidentiary images (e.g., micrographs, medical scans, original experimental data visualizations) that form the basis of scientific claims is strictly prohibited, as it compromises their veracity and auditability. AI may be used for image analysis as part of a defined methodology, which must be fully detailed in the Methods section.
Example:
| "Figure 1. Conceptual pathway of therapeutic intervention. The initial schematic concept was generated using Midjourney (v6.0, March 2024) and subsequently extensively modified and validated for clinical accuracy by the authors using Adobe Illustrator." |
- AI in Manuscript Drafting: Disclosure is required if AI was used to generate draft text for any part of the manuscript or supplementary materials. This must be declared in a dedicated section titled "Generative AI Use Statement” before the References, including:
- The purpose of using the AI.
- The specific sections of the manuscript AI was applied to.
- Name of the tool (with URL), version, and developer.
- Date(s) of use.
Example:
| “The authors used GPT-4 (August 2025) to draft an initial version of the Acknowledgments section and to assist in translating the Methods section from Spanish. The clarity and flow of the Discussion section were improved using Gemini (July 2025). All AI-processed text was thoroughly reviewed, edited, and fact-checked by the authors, who take full responsibility for its final content and accuracy.” |
- AI in Basic Editing Tasks:Consortium Psychiatricumdoes not require disclosure for AI use limited to:
- Grammar, spelling, and general style checking.
- Reference list formatting.
- Translation, provided the output is subsequently verified by a professional translator or native speaker.
Upon detection of AI-generated content coupled with author claims of its auxiliary use, the editorial board reserves the right to request the original pre-AI manuscript drafts, which the authors are obligated to provide.
- Legal Compliance and Data Security
- Before using any AI tool, authors must review its Terms of Service and Privacy Policy. Ensure that the agreement does not transfer exclusive rights to the AI developer for user-generated content and does not restrict its subsequent use by the authors, journal, or publisher.
- Authors must not uploadconfidential, personally identifiable, or unpublished proprietary data to AI platforms without first confirming the service provides adequate, legally compliant data protection safeguards.
- Ethical Considerations and Authorship
- Authors must actively consider and address potential biases inherent in AI outputs and describe steps taken to identify and mitigate them.
- AI tools cannot be listed as authors or co-authorson a manuscript.
- AI may not be cited as an original sourceof information. Content generated by AI (text, images) lacks independent intellectual agency and therefore cannot be referenced. All supporting claims must be sourced to citable, human-generated literature or primary data.
MANUSCRIPT STRUCTURE
EQUATOR Network reporting guidelines
The editorial board of Consortium PSYCHIATRICUM strongly recommends that authors use the EQUATOR Network publication guidelines when preparing manuscripts. A unified standard for reporting research ensures the accuracy, completeness, and transparency of articles. As a result, the scientific reliability and value of published materials are significantly enhanced
- Manuscripts describing original research (including study protocols and systematic reviews) must be submitted to the editorial office in strict accordance with the structure of the checklist from one of the reporting guidelines available in the EQUATOR Network For most studies, one of the following guidelines will be appropriate:
- Observational studies (STROBE)
- Randomized trials (CONSORT)
- Study protocols (SPIRIT)
- Narrative literature reviews (check list)
- Genetic associations (STREGA)
- Survey studies (CROSS)
- Qualitative researches (SRQR)
- Systematic reviews (PRISMA)
- Scoping reviews (PRISMA-ScR)
- Diagnostic/prognostic studies (STARD)
- Prediction models (TRIPOD-AI)
- Case reports (CARE)
- Test adaptation (TARES)
2. The list of guidelines provided is not exhaustive. If none of the indicated guidelines is suitable for your research, please select an appropriate one by searching the EQUATOR Network library (search options are available by study type, clinical area, manuscript section, and keywords).
3. If you experience difficulties in choosing the appropriate guideline, please contact the editorial office at the editor@consortium-psy.com.
4. If your study is reported using an unsuitable guideline, you will be asked to resubmit your manuscript in accordance with the checklist of the guideline relevant to your work.
5. If your manuscript is prepared using checklists from two or more guidelines, please indicate the source for each section of your manuscript.
6. If any checklist item in the chosen guideline does not apply to your study, please indicate “not applicable” or similar (the item heading must be retained). Such items will be removed from the manuscript if your work is accepted for publication.
For details on how to select and work with checklists, please see here.
Manuscript templates
To prepare your submission, please use the official manuscript template corresponding to your article type. These templates provide the required structure and formatting guidelines:
Original Research: Diagnostic Study
Original Research: Observational Study (Medical Intervention)
Original Research: Observational Study (General)
Original Research: Interventional Study
Author statements
At the end of the manuscript, authors must disclose details that could influence the judgment or decisions of editors, readers, other researchers, or other interested parties. Disclosures should take the form of brief statements containing key information on the topic.
- Acknowledgments
All individuals who provided substantial assistance in conducting the research (e.g., data collection or analysis, assistance with writing or editing the manuscript) but do not meet authorship criteria (see authorship criteria here) should be listed in the "Acknowledgments" section, with a specific description of their contribution.
Authors must obtain written permission from all named individuals prior to inclusion in this section. The corresponding author must confirm possession of these permissions.
Example:
Acknowledgments: The authors express their gratitude to faculty members and employees… [the short official name of the organization (country)], specifically Prof. [initials and surname] for histological analysis, and to Prof. [initials and surname] (the short official name of the organization, country) for critical review and assistance in manuscript preparation. [Initials and surname], [initials and surname], and [initials and surname] do not object to being mentioned by name. [This part will not be published.] |
Describe each author's contribution to the research using the CRediT (Contributor Roles Taxonomy) system. Download the table with CRediT roles and roles definitions here.
Authors may fulfill multiple roles, which may also be duplicated.
Typical role description: First author’s full name: role(s) (one or more roles using the CRediT system); second author’s full name: role(s); etc. OR: Use a role as a grouping factor and put the names of corresponding authors after a colon. This is preferable for studies with multiple authors. Please consult the journal’s editor on using this option.
Conclude the section with the statement: "All authors made substantial contributions to the article, reviewed, and approved its final version prior to publication."
Examples:
Authors’ contributions: John M. Doe: conceptualization, investigation, data curation, writing—original draft, writing—review & editing; Disha Srivastava: data curation, writing—review & editing; Juliette James: data curation, investigation, writing—review & editing; Jane Doe: data curation, writing—original draft, writing—review & editing. All the authors approved the version of the manuscript to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
Authors’ contributions: Conceptualization: John M. Doe, Juliette James; investigation, data curation, writing—original draft, writing—review & editing: Juliette James, Disha Srivastava. All the authors approved the version of the manuscript to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
- Ethical considerations (Research studies)
The study authors have ethical obligations to society arising from their use of public resources (financial and non-financial), potential social consequences of their work, the high risk of violating the rights and interests of study participants, inhumane treatment of animals, and mitigation of the potentially negative environmental impact of their study. Given that ethical obligations vary on a case-by-case basis, please describe the actions you took to comply with the generally accepted standards of academic ethics and explain any deviations from these standards.
Report the following:
1) The result of the study protocol approval by an ethics committee or another competent authority with similar functions received prior to the study;
2) Obtaining an informed consent to participate in the study, as well as to use the materials and/or data from participants;
3) Registration of the study (and its protocol).
Any refusal to perform the specified actions must be documented. If no ethics approval statement or informed consent have been obtained, the reasons must be explained.
If you have an ethics approval statement, please provide information about the committee’s opinion (e.g., “the study protocol was approved,” “the request for ethics approval was rejected,”). Specify the type of ethics committee (e.g., independent, local, or other expert authority), its affiliation, the minutes number and the date of signing. The editorial staff may request an electronic copy of the statement, as well as the contact information of the representative of the ethics committee.
When obtaining informed consent, please specify whether the consent is written or verbal; the purpose, such as the use and/or dissemination of materials for research purposes, study participation, etc.
For a registered study, specify the place of registration (platform, database, journal, preprint repository, etc.), registration message identifier (URL, digital identifier, bibliographic record, etc.), and initial publication date of the message.
Examples:
Ethics approval: The study protocol was not reviewed by an ethics committee. No informed consent for participation in the study was obtained. Reason: the study used public data, which does not contain any personally identifiable information about patients. The study was registered at [name of the institution with the URL for study registration message] on [initial publication date of the message in Month dd, yyyy format]. |
Ethics approval: The Independent Ethics Committee of [official name of the institution where the committee operates] rejected the request for an expert review of the study protocol (Minutes No. ... dated [Month dd, yyyy]). Reason: [excerpt from the statement]. All participants provided written informed consent. The study and the its protocol were not registered. |
Ethics approval: The study was approved by the Independent Ethics Committee of [official name of the institution where the committee operates] (Minutes No. ... dated [Month dd, yyyy]). All participants provided written informed consent to participate in the study including the use of study data. The study protocol is available at [URL of the protocol], published on [Month dd, yyyy]. |
Ethics approval: The study was approved by the Local Ethics Committee of [official name of the institution where the committee operates] (Minutes No. ... dated [Month dd, yyyy]). All participants provided written informed consent for the use of their clinical assessment and treatment data for research purposes on admission. The study protocol was published in the [journal reference]. The manuscript was submitted on... [Month dd, yyyy]. |
- Consent for publication
Each manuscript that contains confidential information of an individual (personal data, photographs, protected health information, or any other facts, events, and circumstances of the individual’s personal or professional life), must include a statement on obtaining their informed consent for publication of these data in a journal, including its online version. Personal data of children (individuals aged 0–17 years) can only be published with the permission of their legal representative.
Publication of confidential data of an individual after their death also requires consent of legal representatives. One exception (determined by the importance of provided information) is when legal representatives or immediate family members cannot be located despite reasonable efforts of the authors. In such cases, describe the actions taken to locate legal representatives or immediate family members of the deceased individual.
In cases where informed consent for publication of confidential data was not obtained, specify the reason. This information is published.
In the Ethics Approval section, specify whether informed consent for participation in the study and/or the use of materials and data for research purposes was obtained from participants.
If you have obtained informed consent for publication, please provide the following information:
1) Consent form (verbal or written), signer (patient, legal representative, or other person), and signing date.
2) The authors must confirm that the scope of published confidential data has been agreed upon with the patient and/or their legal representative. This information is published.Insignificant personal information must be removed from the manuscript, even if the authors have obtained informed consent for publication of confidential data.
Examples
Consent for publication: Written informed consent was obtained from the patients [and/or their legal representatives] for the publication of their confidential data, including photographs [with faces obscured], in a scientific journal and its online version (signed on December 25, 2023). The scope of the published data was approved by the patient [and/or their legal representative]. |
Consent for publication: No informed consent was obtained from the patient for publication of information on their health status during hospitalization. Reason: the patient was lost to follow-up (the telephone number specified in the medical record was blocked; the e-mail address was unknown; and contact information of the patient’s family members was unavailable). All data presented are anonymized, and no photographs are published. |
- Funding
Authors must specify the sources of funding for the conducted research and the form of support received (e.g., monetary funds, consumables, equipment, computer software, intangible assets, and services such as logistics, consultations, training, or other third-party services).
Example:
Funding: The research was carried out without additional funding. |
Funding: This research was conducted with financial support from the Russian Science Foundation under scientific project No. XXXXX |
- Data sharing statement
Data refers to any information used (third-party data) or obtained (collected or created) in a study. The authors must report the use of previously published first- or third-party data in the Methods section or other section appropriate for describing the research methodology, as well as in the Statement of originality section. Specify whether the article and/or its supplements present all the data obtained in the study (typical for review papers and case reports). In such cases, the editorial policy of the journal regulates data availability (access to the full text of the article and supplements).
If the article or its supplements do not present any dataset including images, text, code, etc., the following options are possible:
1) Data not available: This statement must be justified, indicating why the data are not available: due to confidentiality, safety issues, ethical, legal, and/or commercial limitations of data sharing.
2) Data subject to restrictions:The reasons and nature of restrictions must be specified (on request, embargo, other [specify]). If the on-request restriction is used, the following must be specified: the form of request (free-form rationale or a request that includes, for example, the planned study protocol, ethics committee approval, statistical analysis plan, signed data use agreement, etc.), contact person (author or representative of the sponsor or another copyright holder), and scope of data that will be made available. If the embargo restriction is lifted, the time until the embargo is lifted must be specified.
3) Data openly available in a public repository:In this case, provide access details, including the data location or source name (e.g., repository or other), the link (or bibliographic reference, URL, or persistent digital identifier of the data location), and the terms of data distribution (e.g., type of open license).
4) Not applicable. No raw data were collected during the study
Access to data from human studies (open or limited, full or partial), including studies of human biological materials and data, requires the permission of individuals (except for anonymized data, which cannot be identified even with additional information) and their legal representatives (in some cases, including after the participant’s death), and ethics committee approval. The authors must report compliance with this condition in the Ethics Approval section.
Examples:
Data sharing statement: All data obtained in this study are available in the article. |
Data sharing statement: All data obtained in this study are available in the article and its supplementary material. In particular, Supplement 1… |
Data sharing statement: The data obtained in this study cannot be made publicly available for confidentiality reasons (the database contains personally identifiable information of study participants, and the participants did not consent to dissemination of this information or private health information). |
Data charing statement: The data obtained in this study cannot be made publicly available subject to a contract with the copyright holder (study sponsor) [name, country]. By agreement with the copyright holder, the study data will be available 12 months after publication of this article upon reasonable request (a brief description of the planned study protocol is mandatory). |
- Generative AI use statement
The authors must specify whether they used generative AI to prepare the manuscript, its parts (including images), or other submitted materials;
If AI is used for these purposes, the authors must specify the technology (or large language models, chatbots), purpose of use (to prepare the manuscript, its parts [specify], images, etc.), tool (software, platform, or service, indicating the URL as applicable), version, developer (country), and time of use (up to the month).
The authors must not list AI as an author or co-author, refer to AI as an author, or cite AI as an author (when using AI-generated texts or images. For more information on the journal’s editorial policy regarding the use of AI, see here.
Examples:
Generative AI use statement: Nothing to disclosure. |
Generative AI use statement: This article [or article (in full or in part), author’s abstract, images, tables, etc.] was prepared using [tool], version [version number] (developer, https://...). The chatbot was used from March to April 2024. |
- Conflict of interest
Conflicts of interest should be declared for all authors in all types of articles. A conflict of interest implies the existence of any relations and/or personal interests that could potentially affect the results, interpretation of the data, and its unbiased perception. A conflict of interest can occur in the case of financial relations and cooperation with any organization (e.g., fees, educational grants, participation in expert councils, membership, work relations, consultancy work, ownership of a shop in a private property, etc.). In addition, a conflict of interest could relate to non-financial interests (e.g., personal or professional relationships, etc.) with regard to issues discussed in the article and/or materials.
If there are no conflicts of interest, please give the following statement at the end of the article:
| Conflicts of interest: The authors declare no conflicts of interest. |
- Information about the authors
For each author, provide the full name, academic degree, title, position, and primary affiliation. Please also include current author identifiers where available: SPIN-code (eLibrary), ORCID iD, Scopus Author ID, Researcher ID. Mark the corresponding author (responsible for editorial correspondence) with an asterisk (*).
Example:
Olga Anatolyevna Karpenko, MD, Cand.Sci (Med.), PrincipalResearcher, Scientific and Clinical Center for Neuropsychiatry, Mental-health clinic No. 1 named after N.A. Alexeev; eLibrary SPIN-code: 9600-0688, RSCI: 9600-0688, Scopus Author ID: 56654984500, ORCID: 0000-0002-0958-0596 |
FORMATTING GUIDELINES
Consortium PSYCHIATRICUM journal follows the "Your Paper, Your Way" policy: we impose no strict formatting requirements at the manuscript submission stage. However, please pay attention to the formatting of the following elements in your work:
Statistical Analysis
For studies with complex structures (involving more than two pairwise comparisons), we strongly recommend consulting a professional statistician.
Please clearly indicate the critical significance level (α) adopted in your study. For example: "The critical significance level for statistical hypothesis testing was set at p < 0.005." Whenever possible, report the actual p-values obtained for each statistical test (e.g., p=0.015 or p=0.267) rather than simply stating "p<0.05" or "p>0.05."
Report the exact values of the statistical tests used. Example: Pearson's χ²=12.3 (df=2, p=0.0001). Avoid ambiguous use of terms that have multiple meanings. For instance, several correlation coefficients exist (Pearson's, Spearman's, etc.) — please specify which one you used.
Define all statistical terms, abbreviations, and symbols used: (M — sample mean; m — standard error of the mean; SD — sample standard deviation; p — achieved significance level).
If the statistical methods you used have specific assumptions or limitations, describe how you verified these assumptions and report the results of such verification. For example, when using parametric methods, it is important to specify which test was used to confirm normality (Kolmogorov–Smirnov, Shapiro–Wilk, Anderson–Darling, D'Agostino–Pearson). Please note: expressions such as M ± m and M ± SD for describing quantitative variables are acceptable only when the data are normally distributed. Always report the sample size (n).
When using the parametric Student's t-test, equality of variances should first be tested, and Welch's correction applied if necessary. For analysis of variance (ANOVA), please report the test used to assess homogeneity of variances (Fisher's, Cochran's, Bartlett's, Levene's, or Dunnett's test).
If you are comparing more than three groups, describe the method used to adjust for multiple comparisons.
When assessing risks, it is important to distinguish clearly between odds ratios, risk ratios, relative risk, and absolute risk.
Please specify the statistical software package used for data analysis, including the version number, manufacturer, and country of origin. Example: "Statistical analysis was performed using STATISTICA v.13 (StatSoft, USA)." Acceptable software includes but is not limited to: BMDP, STATGRAPHICS, MINITAB, MEDCALC, SYSSTAT, STATISTICA, SPSS, R, CSS, STADIA, ЭВРИСТА, САНИ, BIOSTAT, MESOSAUR, DATASCOPE, STATA, SAS, EPIINFO, SOFA, MS EXCEL, S-PLUS, MSL-C, STAT-MEDIA, NCSS, JMP, and others.
For more detailed guidance on reporting statistical methods and results, please refer to the SAMPL guidelines (Statistical Analyses and Methods in the Published Literature).
References
Justification of statements
Every author statement must be justified either by reference to the authors' own opinion (e.g., "in our view," "we believe," or similar phrasing), including opinions based on personal experience (e.g., "unpublished data"), or by citing other researchers' opinions or results from prior studies. The latter two justification types must be supported by bibliographic references.
If a single sentence or paragraph contains multiple statements, references should be attached to each one individually, rather than placed only at the end of the sentence or paragraph.
Number and priority of sources
No more than three primary sources should be cited to justify a single statement. Systematic reviews are an exception, allowing broader citation.
Priority should be given to primary sources: original research studies (including applicable systematic reviews), clinical guidelines from professional societies, and consensus documents. Only in their absence may references be made to expressed opinions (including those in review articles), clinical case descriptions, or non-peer-reviewed sources (preprints, press releases). The status of such sources must be clearly indicated in the text.
Secondary sources (including reviews) should be cited cautiously—for instance, when the original work is no longer in print, unavailable through standard channels, or not available in its original language.
Mentioning authors in the text
Authors' surnames from cited works (e.g., "Smith et al.") should be mentioned only if the reference adds semantic value beyond the study results themselves. Otherwise, including authors' names in the main text is unnecessary.
In-text citation formatting
In-text references to sources are given in square brackets using Arabic numerals, e.g., [1, 2] . Numbering must follow the order of citation in the text.
Reference list
Each reference should be listed on a new line with its ordinal number. The reference list is ordered by the sequence of citations in the text. Include the most recent publications relevant to the article's topic.
Bibliographic description:
- All bibliographic references must be formatted according to NLM (National Library of Medicine) style. Formatting guide: https://www.ncbi.nlm.nih.gov/books/NBK7256/.
- For automated formatting, use the service https://www.citethisforme.com or copy ready-made citations from PubMed https://pubmed.ncbi.nlm.nih.gov/40927413/.
- All authors must be listed in the source description. If a publication has more than four authors, use "et al." after the third author name.
- Article titles must not be abbreviated.
- Journal titles in English should follow the Medline catalog; if not indexed in Medline, use the full title.
DOI
If the cited material has a digital object identifier (DOI), it is placed at the end of the bibliographic reference. Check for DOI availability at: http://search.crossref.org/.
Sources excluded from the reference list
The following source types must not be included in the reference list; references to them should be formatted as footnotes:
- unpublished works (including full dissertation texts);
- government documents (laws, decrees, etc.);
- historical documents;
- newspaper articles.
Illustrations
Illustrations (photographs, figures, diagrams, charts, maps) serve to visually present research findings.
Consortium PSYCHIATRICUM journal maintains neutrality with respect to jurisdictional claims expressed in published maps.
The submission and publication of images created using artificial intelligence, machine learning tools, or similar technologies is discouraged, except where such content forms part of formal research design or methodology. Publication of AI-generated images is permitted only if accompanied by a clear description of the content created, the name of the model or tool used, its version and extension numbers, and the manufacturer. Authors bear full responsibility for the integrity of content generated by these models and tools.
Graphs, charts, and diagrams may be edited to conform to the style and standards of Consortium PSYCHIATRICUM prior to publication.
- Illustrations upload
Illustrations may be embedded directly within the text of the manuscript. However, if this is technically unfeasible or compromises image quality, files should be uploaded separately at Step 3 of the submission process. Each illustration must be cited in the text.
- File requirements
1. For raster images (photographs), submit files in TIFF or JPEG format with a minimum resolution of 300 dpi.
2. For vector images (diagrams, charts, graphs), provide editable source files (native formats from software such as AI, EPS, SVG, CDR, XLS, PPT, DOCX).
3. Each file should be named according to its figure number (e.g., Figure 1. Flow diagram.tiff).
4. If there is any possibility that a patient may be identified from a photograph, its legend, or accompanying text, authors must obtain written informed consent from the patient for publication in Consortium PSYCHIATRICUM.
- Requirements for graphs and charts
All symbols, indicators (including error bars), line styles, colors, and abbreviations must be defined in the legend beneath the figure. Every axis in a statistical graph must be labeled with its name and units of measurement. Do not use pie charts, three-dimensional (3D) graphs, or stacked bar charts, as these are unsuitable for accurate statistical presentation of data. Such data should be reformatted as another graph type or converted into a table.
- Figure legends
Each illustration in the manuscript must be accompanied by a legend. The legend should be self-explanatory, enabling the reader to understand the content of the figure without reference to the main text. The legend must include the following elements:
1. Title and figure number. The title should be concise and descriptive. Do not use abbreviations in titles (even if they have been introduced in the main text). If abbreviations are necessary, they must be explained in the notes.
2. Note. This section contains explanations of all symbols (letters, numbers, graphical marks) and abbreviations used in the illustration.
3. Copyright information. A mandatory component confirming the legal status of the image.
- For original illustrations (created by the authors of the manuscript): copyright information is not included in the figure legend, as it is covered by the general copyright provisions of the article.
- For borrowed illustrations (previously published or owned by third parties): reproduction is permitted only with written permission from the copyright holder, which must be submitted to the editorial office. The legend must acknowledge the copyright holder and cite the source of the borrowed material.
Tables
Tables should be placed directly within the article text. Columns (headings) must be titled clearly to facilitate easy reading and analysis of the data. If a table cannot be accommodated within the manuscript text, it may be uploaded as a supplementary file at Step 3 of the manuscript submission process. Each table must be referenced in the article text using its number.
Table numbering must be consecutive throughout the manuscript (e.g., Table 1, Table 2). Even a single table requires numbering. Abbreviations are not permitted in table titles.
Data presented in tables must correspond exactly to the manuscript text. However, verbatim repetition of numerical data from tables in the text is prohibited.
For all statistical measures, specify the analysis method used, the obtained value, and the corresponding level of statistical significance (p-value). Empty cells in tables are not allowed.
Explanations of all abbreviations and symbols used in the table must appear in a note below the table. The table's core content (title and note) must be comprehensible to readers without reference to the manuscript text.
Genetic nomenclature
Authors must verify gene and product names in relevant databases and use current, standardized symbols because genetic nomenclature varies among species. For gene and product names, see here and here.
Avoid using terms such as polymorphism or mutation for reference nucleotide variants differing from the reference nucleotide sequence. Use neutral terminology instead, such as variant or substitution (single nucleotide variant, SNV).
The first time a gene is mentioned in the text (outside the abstract), a footnote describing the gene in the relevant database should be included. Example: HLA-DRB1 [1].
Use italics for gene symbols, genotypes, messenger ribonucleic acid (mRNA), complementary DNA (cDNA), and mobile genetic elements. Do not italicize full gene names, protein products, and phenotype descriptions. Do not use Greek letters, Roman numerals, dashes, hyphens, superscripts, or subscripts for the gene symbol, unless they are being used to designate a gene product or phenotype.
Example:
Gene | Poly(ADP-Ribose) Polymerase 1 |
Gene symbol | PARP1 |
Protein | PARP1 |
Genotype | PARP1+/- |
Phenotype | PARP1+ |
mRNA | mRNA PARP1 |
cDNA | cDNA PARP1 |
Mobile element | TY |
Gene symbols may be written in uppercase or lowercase, depending on species-specific nomenclature rules.
Example:
Species | Gene (symbol) | Protein |
Escherichia coli | rdgB | RdgB |
Saccharomyces cerevisiae | ADE2 | Ade2 |
Homo sapiens | POLD1 | Pol δ |
Mus musculus | Tnfa | TNF-α |
Human genomic variants should be described in accordance with the Human Genome Variation Society (HGVS) nomenclature.
Example:
Gene | Tumor protein p53 |
Symbol | TP53 |
Gene Nomenclature Committee ID | HGNC:11998 |
Genotype variants: | |
Position of cDNA substitution | TP53: c.488A>G |
Genomic position (including the reference sequence) | TP53: g.7578442T>C (GRCh37.p13 chr 17 NC_000017.10) |
Position of protein substitution | p.Tyr163Cys |
Cis-heterozygosity | g.[7578442T>C;7577129A>C] |
Trans-heterozygosity | g.[7578442T>C];[7577129A>C] |
Heterozygote with unknown allelic configuration | g.[7578442T>C](;)[7577129A>C] |
The nomenclature for genetic variants varies by organism. Please verify the correct notation in the corresponding databases. The first time a gene is mentioned in the text (outside the abstract), a footnote describing the gene in the relevant database should be included.
Example: HLA-DRB1 (https://omim.org/entry/142857?search=HLA-DRB1&highlight=hla).
MANUSCRIPT SUBMISSION
How to submit a manuscript
Manuscripts and supplementary materials are submitted via the online submission system on the journal's website. Helpful resources for using the online submission system: video tutorial and PDF instructions.
To submit a manuscript, you must first register as an author. When submitting, please clearly identify the author responsible for correspondence with the editorial office (corresponding author). All communication regarding the manuscript will be conducted with this individual.
Submission is completed in several steps:
Step 1. Select the section/category and the language of the full-text article. Carefully read all items in the submission checklist and indicate your agreement by checking the boxes.
Step 2. Upload the file containing the full text of your manuscript.
Step 3. Upload all prepared cover letters, supporting documents, and supplementary files.
Step 4. Provide complete information for all authors. Please ensure authors are listed in the correct order.
Step 5. Enter the manuscript metadata: title, abstract, keywords, funding information, and reference list.
Step 6. Copy and paste the full text of the manuscript into the designated field.
Step 7. Click the "Submit" button. Your manuscript will not be received by the editorial office until you complete this final step.
After successful submission, the corresponding author will receive an automated confirmation email acknowledging receipt of the manuscript. If you do not receive this email, the submission process is incomplete. Please return to your submission and complete the final step.
The editorial office may request additional information, clarifications, or supplementary materials from the authors at any stage. This may include, but is not limited to, raw data, detailed descriptions of methodology, or statistical summaries. Timely responses to editorial queries are essential; failure to respond may result in delays or the manuscript being withdrawn from consideration.
For any questions regarding the submission platform or technical issues, please contact us at: editor@consortium-psy.com
Cover letter
In addition to the main manuscript file, a cover letter signed by all authors must be uploaded during submission (download template). The manuscript will not be reviewed without the cover letter.
Author fees
There are no article processing charges (APCs) for authors.All services, including scientific editing, copyediting anf proofreading, translation, NLM reference formatting, typesetting, promotion, and a printed author copy of the journal, are provided free of charge.
What happens after manuscript submission
Once you submit your manuscript through our online system, it enters our editorial workflow and undergoes several review stages. A detailed description of the peer review process is available in the journal's Editorial Policies.
The corresponding author receives all manuscript status updates. You can also track your manuscript's progress anytime in your personal dashboard on the journal website.
During peer review and scientific editing we may ask you to revise your manuscript based on reviewers' and editors' comments. You will typically have two weeks to make these changes, but we are happy to grant extensions upon request. Please stay in touch: if we do not receive a response from you for three months, the manuscript will be automatically withdrawn.
Limit on review rounds
To ensure the efficient use of our editors' and reviewers' time, manuscripts are limited to a maximum of three rounds of review. If a fourth (or subsequent) round is required due to delays on the part of the authors, such as repeatedly overlooking feedback or submitting incomplete revisions that necessitate fresh reviews, authors will be required to cover the cost of each additional round. Fees are calculated individually based on the manuscript's length and complexity.
AFTER PUBLICATION
Publishing an article in Consortium PSYCHIATRICUM is just the beginning of our efforts to integrate your work into the scientific and professional community.
The editorial office uses a comprehensive set of tools to increase the visibility of published research, both within academic circles and beyond.
- Media Outreach. The journal's PR service prepares press releases for published studies and, after approval from the authors, offers them to leading medical media outlets. For examples of media coverage of our journal, please see here.
- Social Media. The editorial office actively promotes new publications across social media channels:
Substack: https://substack.com/@consortiumpsychiatricum
BlueSky: https://bsky.app/profile/consortiumpsy.bsky.social - Email Newsletter. Notifications of new issues, including a brief overview of the contents, are sent to mental health professionals.
- Author Interviews. The editorial team conducts interviews with authors, offering researchers an opportunity to present their work to the professional community and discuss the background and findings of their study.
- Video Abstracts. Authors may prepare short videos summarizing the key points of their article. These videos are shared on social media and video platforms.
- Podcasts. Based on recent publications, the editorial office produces thematic podcasts, providing the audience with an opportunity to engage with scientific findings in an audio format.
Offline Promotion
Editorial board members present the journal and its publications at national and international scientific meetings. The editorial office hosts information booths at major conferences in the field, offering consultations for authors and readers, presenting the journal's editorial policies, and distributing print copies.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.
The authors confirm that the manuscript complies with all formatting and preparation requirements outlined in the journal's Author Guidelines.
Before submitting your manuscript to the journal, run it through our in-house AI editor to check compliance with editorial requirements. This will help identify and fix any major issues, speeding up the initial review process.
The authors confirm that the manuscript complies with the journal's Ethical Policy and accept full responsibility for its adherence.
The authors guarantee the originality of the work, affirming it has not been published (in whole or in part) and is not under review or in press at any other publication.
Any prior submission(s) of this manuscript to other journals must be disclosed in the cover letter, including the outcome (e.g., rejection).The authors confirm that the structure and content of the manuscript comply with the relevant EQUATOR Network reporting guideline.
The list of reporting guidelines
- Observational studies (STROBE)
- Randomized trials (CONSORT)
- Study protocols (SPIRIT)
- Narrative literature reviews (check list)
- Genetic associations (STREGA)
- Survey studies (CROSS)
- Qualitative researches (SRQR)
- Systematic reviews (PRISMA)
- Scoping reviews (PRISMA-ScR)
- Diagnostic/prognostic studies (STARD)
- Prediction models (TRIPOD-AI)
- Case reports (CARE)
- Test adaptation (TARES)
The list of guidelines provided is not exhaustive. If none of the indicated guidelines is suitable for your research, please select an appropriate one by searching the EQUATOR Network library (search options are available by study type, clinical area, manuscript section, and keywords).
If you experience difficulties in choosing the appropriate guideline, please contact the editorial office (editor@consortium-psy.com).
For details on how to select and work with checklists, please see here.
Authors confirm that they have prepared and will upload the following supporting documents at Step 3 of the submission process:
- A cover letter signed by all authors (download template).
- The appropriate reporting guideline checklist (e.g., CONSORT, STROBE, CARE), completed with the manuscript section or page numbers provided for each required item.
- A scanned copy of the official Ethics Committee approval (for research studies).
The authors confirm that they have reviewed the journal's Artificial Intelligence (AI) Policy and have disclosed the use of AI in the "Generative AI" section at the end of the manuscript or within the Methods section. Authors grant the journal the right to screen the manuscript using dedicated tools to detect AI-generated text.
Upon detection of AI-generated content coupled with author claims of its auxiliary use, the editorial board reserves the right to request the original pre-AI manuscript drafts, which the authors are obligated to provide.
The manuscript does not contain any third-party copyrighted materials (images, tables, or substantial text excerpts) whose use requires written permission from the copyright holder.
Should any such materials be included, the corresponding written permissions have been obtained by the authors and will be made available to the editorial office upon request.The authors confirm that research involving human subjects has obtained formal, prospective approval from an independent ethics committee.
For all research involving human participants, it is required to:
- Upload a scanned copy of the official ethics approval document at Step 3 of the manuscript submission process. The document must include the full name of the ethics committee, its affiliated institution, and the approval protocol number.
- Describe the process of obtaining informed consent from participants within the manuscript.
- Provide a justification in the manuscript if the requirement for ethics approval was formally waived by the committee.
Authors are encouraged to share the data underlying their findings and include a Data Availability Statement in the manuscript.
Authors may share the data via a public repository (e.g., Zenodo, Mendeley Data) or by uploading the files to the journal’s submission system at Step 3 of the submission process.
Where data cannot be made publicly available for ethical or legal reasons, the manuscript must contain a clear description of the procedure for requesting controlled access.
For clinical trials: The authors confirm that a clinical trial was registered in a public registry prior to enrollment of the first participant. The report has been prepared in accordance with the CONSORT guideline and includes the trial registration number.
Copyright Notice
Authors who publish with this journal agree to the following terms:
- Authors transfer article copyright to the publisher only after the acceptance to publication.
- Authors are able to use and distribute the article in accordance with Self-Archiving policy of the journal (see details).
- The article can be accepted for publication only by decision of the Editor-in-Chief and the Editorial board of the journal in accordance with the Manuscript stelection policy of the journal (see details).
- Published Article will be distributed in print and electronic version an will be available under subscription with Delayed Open Access or in Immediate Open Access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). The access model depends on the publisher's decision or is determined by a separate Open Access publishing agreement with the authors.
Other copyrights not directly transferred to the publisher under the License Agreement, including patent rights to any process, method etc., described by the Authors in the article, as well as trademark rights, are reserved for the Authors.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Consortium PSYCHIATRICUM'.
READ the details online (tap to see in details)
Copyright transfer agreement for publishing a scientific work in a scientific journal (public offer)
ver. 18.11.2025
LLC "Eco-Vector", represented by its CEO Evgeniy Schepin acting on the basis of the Charter (“Publisher”), on the one part, offers an indefinite number of persons (“Author”), on the other part, hereinafter jointly referred to as the Parties, to execute this agreement (“Agreement”) on the transfer of the exclusive right to the intellectual property – the scientific article and its publication in the Publisher’s journal under the following conditions.
I. General Provisions
- This Agreement, in accordance with clause 2 of Article 437 of the Civil Code of the Russian Federation, is a public offer (“Offer”), full and unconditional acceptance of which, in accordance with Article 438 of the Civil Code of the Russian Federation, means the sending by the Author of his/her materials by uploading the same to the online electronic manuscript submission system, placed in the corresponding section of the Journal’s website on the Internet information and telecommunications network (“Internet”).
II. Terms used in the Agreement
- “Author” refers to an individual (or individuals) whose creative work has led to the creation of the manuscript of a scientific Article, or to an authorized representative of these persons.
- “Manuscript” is the result of intellectual activity in the form of a scientific work containing text, graphic and numerical data, audiovisual information, program code and other elements submitted by the Author for publication in the Journal.
- “Acceptance of the offer” refers to the full and unconditional acceptance of the offer on the terms specified in paragraph 3 of this agreement (the Author accepts offer by submitting a Manuscript to the Publisher via the online electronic manuscript submission system on the Journal’s Internet website).
- “Journal” is a scientific peer-reviewed periodical (and/or online media) registered as a mass media entity in the register of Federal Service for Supervision of Communications, Information Technology, and Mass Media (Roskomnadzor).
- “Submission” is an electronic application of the Author to the Publisher for the publication of an Article Manuscript in the Journal by uploading the manuscript, additional files and accompanying materials to the online electronic manuscript submission system on the Journal’s Internet website).
- “Publisher” refers to Eco-Vector LLC.
- Article metadata includes the information on the Article Manuscript and/or Article that are intended for inclusion in International Scientific Databases, namely the following:
- Title of the Article;
- Information about each of the Authors (surname and first name, patronymic; place of work with the postal address indicated, contact information (e-mail));
- Abstract;
- Keywords;
- Thematic rubricator: UDC (Universal Decimal Classification) or other library and bibliographic classification and subject indexes;
- List of references.
- “Offer” is the current agreement (an offer to the Author for the publication of an Article in the Journal).
- “Publication” is the process of placement of an Article in the Journal.
- “Article” is an article’s manuscript that has undergone the process of peer-review and editorial and publishing processing.
- “Editorial board” is the creative team that prepares the journal for publication.
- “Parties” refers to the Author and the Publisher.
- “Author Guidelines” are the requirements for Articles and additional materials to be published in the Journal (their design, structure, content, originality, ethics), placed in the “For authors” section of the Journal’s Internet website.
III. Subject of the Agreement (Offer)
- Under this Agreement, the Author transfers to the Publisher on a gratuitous basis for the entire term of validity of exclusive copyright provided for by the legislation of the Russian Federation, the exclusive (property) right to the Article created by the Author, including (but not limited to) the following rights:
- Reproduction of the Article or its sections or parts, as well as the metadata of the Article in Russian and foreign languages, in any material form, including on paper and electronic media, as a separate work in Journals and/or databases (local or in the Internet) of the Publisher and/or other persons, at the discretion of the Publisher;
- Distribution of the Article or its sections or parts, as well as the metadata of the Article in Russian or foreign languages, on any medium as part of the Journal and/or databases of the Publisher or other persons, at the discretion of the Publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;
- Making the Article or any of its sections or parts, as well as the Article’s metadata in Russian or foreign languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choice;
- Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in Russian or foreign languages, to third parties with notice to the Author made by posting relevant information on the Journal’s website, without paying remuneration to the Author;
- Processing the Article, including translating to any languages and using the revised (translated) Article in the aforementioned ways.
- Other rights not directly transferred to the Publisher under this Agreement, including patent rights to any process, method etc., ideas or discoveries described by the Author in the Article, as well as trademark rights, will be retained by the Author.
- The terms and conditions of this Agreement, obliging the Publisher to publish the Article, on the transfer of the exclusive right to the Article to the Publisher, as well as the terms and conditions granting the Publisher and the Author the right to use the Article in accordance with the Agreement, will take effect only in case of acceptance of the Article for publication in the Journal (condition precedent). The moment of acceptance of the Article for publication in the Journal is the moment of sending the notification of acceptance of the Article for publication to the Author from the official e-mail of the Journal.
- The rights are transferred by the Author to the Publisher free of charge, publication of the Article in the Journal does not entail any financial obligations of the Publisher towards the Author.
- If the Editorial board decides to reject the Submission or refuse to publish the Article in the Journal (i.e., retraction of the published Article), this Agreement becomes invalid. The decision to refuse publication (retraction of the published Article) will be sent to the Author at the e-mail address specified in the Submission.
IV. Rights and Duties of the Parties
- The Author guarantees that:
- He/she is a legal holder of the copyright to the materials submitted to the Publisher as part of the manuscript of the Article;
- The rights transferred to the Publisher under this agreement have not been previously transferred and will not be transferred to third parties;
- The manuscript of the Article contains all references to the cited authors and/or publications (materials) provided for under the current copyright legislation;
- The Author has obtained all the necessary permissions for all deliverables, facts and other borrowed materials he/she holds no copyright to and that are used in the manuscript of the Article;
- The Article manuscript contains only materials permitted to be published in the open press in accordance with the current legislative acts of the Russian Federation, and its publication and distribution will not lead to the disclosure of secret (confidential) information (including state secrets);
- The Author has informed co-authors about the terms of this Agreement and has received their consent to execute this Agreement under the terms provided for in the Agreement.
- The Author undertakes:
- To make amendments to the manuscript of the Article in accordance with the Author Guidelines posted on the Journal’s website and recommendations of the Editorial board;
- Not to use an electronic copy of the Article for commercial purposes and in other journal publications without the consent of the Publisher;
- in the process of preparing a manuscript for publication, the Author undertakes:
- To make corrections to the text of the manuscript that have been marked by the peer-reviewers and accepted by the Editorial board, and/or as necessary, upon the request of The Publisher and the Editorial board, finalize the manuscript of the Article;
- In a timely manner (within the deadlines specified by the Editorial board) to review and coordinate the editorial revisions made to the manuscript (including answering the editors' questions), and proofread the made-up Article (original layout in PDF);
- While proofreading, suggest only the minimum of corrections to the made-up Article in order to eliminate factual errors made.
- The Author has the right to:
- Make changes to the Article (both during the review process and in the process of preparing the Article for publication and after publication);
- Use preprint or prior-to publication electronic versions of an unpublished Article in the form and content accepted by the Publisher for publication in the Journal. Such prior-to-publish versions can be placed as electronic files on the personal websites of the Author (co-authors) or on the protected external websites of the employers of the Author; however, the Author cannot use the unpublished version(s) for commercial use or for systematic external distribution by a third party The author or co-authors must:
- Include the following warning in the prior-to-publish version: “This is prior-to-publish version of the article accepted for publication in (Journal’s name), © Eco-Vector (year)”;
- Provide the corresponding electronic link to the Publisher’s website at https://journals.eco-vector.com/ and/or via the DOI.
- Copy or transfer a copy of the published Article in whole or in part to colleagues free of charge for their personal or professional use, for the promotion of academic or scientific research, or for informational purposes of the Author’s employer.
- Use materials (including data, text, images, tables) from a published Article in a book written by any co-author or other non-periodical scientific or educational publication.
- Use figures, tables, data and text excerpts from the Article for his or her own education purposes, or to include them in other works to be published in print or electronic format by a third party, or to submit them in electronic format on an internal computer network protected from uncontrolled use, or on the public website of the Author (co-authors) or his/her employer.
f) Include the Article materials in educational and methodical works distributed free of charge within the educational process among students (cadets, graduate students, doctoral students) of the Author (co-authors) or to save the Article in electronic format on the local server for students' access (as to the methodical material necessary for mastering within the training), as well as for internal training programs in the institution of the Author's employer. - Withdraw the Submission for publication of the Article until the Editorial board of the Journal makes a final decision on the possibility of publication.
- The Publisher undertakes:
- To carry out editorial and publishing preparation of the Article (copyediting and academic editing, formatting, bibliographic design, layout, proofreading, checking of corrections made, translation of the description of the Article or full-text translation – at the option of the Publisher) in accordance with the editorial standards of the Publisher and the original layout accepted at the time of publication;
- To publish the Author’s article in the Journal in printed and electronic form in accordance with the terms of this Agreement;
- If necessary, as so decided by the Journal’s Editorial board, to provide the Author with the made-up Article and make a reasonable editing;
- To provide to the Author the unlimited access to the final electronic version of the published Article through the Author’s personal account on the Journal’s website from the date of publication of the corresponding issue of the Journal;
- To comply with the copyrights as provided for by the current legislation, as well as protect them and take all necessary measures to prevent copyright infringement by third parties.
- The Publisher has a right to:
- Make any decision on the Author's Submission for publication of the Article, including "accept for publication", "refuse to publish" and "recommend revision of the Article for re-evaluation" (the right to evaluate the Article and make decisions on publication of the Article is managed by the Editorial board of the Journal headed by the Editor-in-Chief);
- Conduct an expert evaluation of the Article manuscript and invite the Author to make the necessary changes (revisions) to the manuscript. The Article will not be published in the Journal unless such changes are not made.
- Independently determine the issue of the Journal for the publication of the Article, make decisions on the terms of publication and their changes, on the withdrawal of the Article and its retraction in cases stipulated by the Code of Ethics of the Publishing House (see details: https://eco-vector.com/Eco-Vector_Ethic_Policy.php);
- Provide technical editing, copyediting of the Article’s manuscript without altering the main content;
- Require from the Authors and all target audience of readers to indicate the correct reference to the final version of the Article published in the Journal (name of the Journal, Publisher, Author, title of the Article, issue number of the Journal and year of publication indicated in the Journal, DOI);
- Post preliminary and/or advertising information about the upcoming publication of the Article in the media and other information sources;
- Make changes to the Offer in accordance with the procedure established by the Offer.
- In all cases not stipulated and not provided for in this agreement, the parties are obliged to be guided by the relevant current laws of the Russian Federation.
V. Acceptance of the Offer and Execution of the Agreement. Validity of the Agreement
- The Author accepts the Offer by submitting the manuscript of the Article to the Publisher through the electronic manuscript submission system on the Journal's Internet website.
- Acceptance of the offer by the Author creates an Agreement in writing (Articles 438 and 1286.1 of the Civil Code of the Russian Federation) on the terms of the offer.
- This Agreement is valid for the duration of the exclusive rights to the Article.
VI. Procedure for changing and terminating the Agreement
- The Publisher has the right to unilaterally change the terms of this Agreement, in advance, at least ten (10) calendar days before the entry into force of the intended relevant changes, but with notice to the Author through the Journal’s website or by e-mail to the Author’s e-mail address specified in the Author’s Submission. The changes will take effect from the date specified in the relevant notification.
- If the Author rejects the changes to the terms of this Agreement, he/she has the right to notify the Publisher by sending a written notification through the online manuscripts submission system placed in the corresponding section of the Journal’s website on the Internet, or by sending a notification to the official e-mail address of the editorial office.
- This Agreement may be terminated prematurely, either by agreement of the parties at any time, or on other grounds provided for in this Agreement.
- The Author has the right to unilaterally withdraw from the execution of this Agreement by sending the Publisher a corresponding notification in writing at least sixty (60) calendar days in advance before the expected date of publication of the Article in the Journal.
- Termination of the Agreement for any reason does not release the parties from liability for any violation of the terms of the Agreement that occurred during the validity period.
VII. Responsibility
- The parties are responsible for non-fulfillment or improper fulfillment of their obligations under the Agreement in accordance with the current relevant legislation of the Russian Federation.
- All information provided by the Author must be reliable. The author is responsible for the accuracy and completeness of the information and guarantees he/she transfers to the Publisher. When using false information received from the Author, the Publisher is not responsible for the negative consequences caused by his actions on the basis of the false information provided.
- With regard to the content of the Article, the Author is solely responsible for compliance with the requirements of the laws of the Russian Federation pertaining to advertising, copyright and related rights’ protection, protection of trademarks and service marks, and the protection of consumer rights.
- The Publisher will have no liability under the agreement:
- for any actions that are a direct or indirect result of Author’s illegal actions
- for any loss incurred by the Author, regardless of whether the Publisher could have foreseen the possibility of such losses or not.
- The Publisher is released from liability for violation of the terms of the Agreement if such violation is caused by force majeure, including actions of state authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, lack of electricity and/or computer network failures, strikes, civil unrest, riots, and any other circumstances directly affecting the ability to fulfill the obligations of the Parties.
VIII. Dispute resolution
- Disputes and disagreements will be resolved by the Parties through negotiations, and in case of failure to reach an Agreement they will strive to seek resolution in accordance with the current legislation of the Russian Federation.
- If there are unresolved disagreements, the Parties agree to resolve the disputes in court at the location of the Publisher in accordance with the current legislation of the Russian Federation.
IX. Miscellaneous
- All notifications, messages, requests, etc. (with the exception of documents that must be sent as originals in accordance with the laws of the Russian Federation) are considered received by the Author if they were transmitted (sent) by the Publisher through the Journal’s website (including by publication), by e-mail and other communication channels specified in the Submission, and other communication channels. The parties recognize the legal force of notifications, messages, requests, etc., transmitted (sent) by the above methods.
- In the event of claims against the Publisher related to the violation of the exclusive copyright and other intellectual property rights of third parties when creating an Article or in connection with the execution of this Agreement by the Author, as well as in connection with the use of the Article by the Publisher in accordance with the Agreement, the author undertakes:
- To immediately take measures to resolve disputes with third parties soon after receiving Publisher’s notification, and if necessary, enter into legal proceedings on the Publisher’s side and take all appropriate actions needed to exclude the Publisher from the list of defendants;
- To reimburse the Publisher for the court costs incurred, expenses and losses caused by the application of measures to secure the claim and execute a court decision, and the amounts paid to a third party for the violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Publisher in connection with the Author’s non-compliance with the guarantees provided by them under this Agreement.
X. Legal address and details of the Publisher
- Eco-Vector
- Address: 191186, St. Petersburg, Aptekarsky Pereulok, 3 letter A, room 1N
- TIN: 7806423692; KPP: 784101001; OGRN: 1099847039907.
Privacy Statement
The editorial office guarantees the confidentiality of personal data. The authors' names, affiliations, and email addresses provided during submission will be used exclusively for the journal's editorial purposes.
Following manuscript acceptance, the email address of the corresponding author, along with the affiliations and academic positions of all co-authors, will be published in the "Information about the authors" section of the article, both in the print version and on the journal's website.